Patients are being recruited for a trial to determine whether chemicals in cannabis can slow the impact of multiple sclerosis. Evidence suggests the drug may relieve symptoms but the three-year national trial is also to determine whether it slows the disease’s...
June 20th, 2011 By: Paul Armentano, NORML Deputy Director The combined administration of the plant cannabinoids THC and CBD (cannabidiol) provide neuroprotection in rat models of Huntington’s Disease (HD), according to experimental data to be published in theJournal...
June 14th, 2011 By: Paul Armentano, NORML Deputy Director The long-term administration of delta-9-THC, the primary psychoactive compound in marijuana, is associated with decreased mortality in monkeys infected with the simian immunodeficiency virus (SIV), a primate...
![Multiple sclerosis changes man's outlook on marijuana]()
Today, at age 54, Timmons is mostly bedridden and rarely sees the outside of his Garland home. What he lacks in physical ability, however, he more than makes up for with his ardent support for legalizing marijuana for seriously ill people. In fact, he has become the...
While by no means an anti-prohibitionist document, this World Health Organization report makes a number of interesting points. The report notes, “despite intensive interdiction efforts, there always seems to be enough [drugs] available to users.”...
